期刊文献+

Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo 被引量:16

Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo
下载PDF
导出
摘要 AIM:To investigate whether bone marrow-derived denritic cells pulsed with tumor lysates induce immunity against gastric cancer ex vivo. METHODS:c-kit+hematopoietic progenitor cells were magnetically isolated with a MiniMACS separator from BALB/c mice bone marrow cells.These cells were cultured with cytokines GM-CSF,IL-4,and TNFα to induce their maturation.They were analysed by morphological observation,phenotype analysis,and mixed lymphocyte reaction(MLR).Bone marrow-derived DCs(BM-DCs)were pulsed with tumor cell lysate obtained by rapid freezing and thawing at a 1:3 DC:tumor cell ratio.Finally,cytotoxic T lymphocyte (CTL)activity and interferon gamma(IFNγ)secretion was evaluated ex vivo. RESULTS:c-kit+hematopoietic progenitor cells from mice bone marrow cells cultured with cytokines for 8 d showed the character of typical mature DCs.Morphologically,observed by light microscope,these cells were large with oval or irregularly shaped nuclei and with many small dendrites.Phenotypically,FACS analysis showed that they expressed high levels of Ia, DEC-205,CD11b,CD80 and CD86 antigen,moderate levels of CD40,and negative for F4/80.Functionally, these cells gained the capacity to stimulate allogeneic T cells in MLR assay.However,immature DCs cultured with cytokines for 5 d did not have typical DCs phenotypic markers and could not stimulate allogeneic T cells.Ex vivo primed T cells with SGC-7901 tumor cell lysate-pulsed(TP)DCs were able to induce effective CTL activity against SGC-7901 tumor cells (E:T=100:1,69.55%±6.05%specific lysis),but not B16 tumor cells,and produced higher levels of IFNγwhen stimulated with SGC-7901 tumor cells but not when stimulated with BB1166 tumor cells(1575.31±60.25 pg/mL in SGC-7901 group vs 164.11±18.52 pg/mL in B16 group,P<0.01). CONCLUSION:BM-derived DCs pulsed with tumor lysates can induce anti-tumor immunity specific to gastric cancer ex vivo. AIM: To investigate whether bone marrow-derived denritic cells pulsed with tumor lysates induce immunity against gastric cancer ex vivo. METHODS: c-kit+ hematopoietic progenitor cells were magnetically isolated with a MiniMACS separator from BALB/c mice bone marrow cells. These cells were cultured with cytokines GM-CSF, IL-4, and TNFα to induce their maturation. They were analysed by morphological observation, phenotype analysis, and mixed lymphocyte reaction (MLR). Bone marrowderived DCs (BM-DCs) were pulsed with tumor cell lysate obtained by rapid freezing and thawing at a 1:3 DC:tumor cell ratio. Finally, cytotoxic T lymphocyte (CTL) activity and interferon gamma (IFNγ) secretion was evaluated ex vivo. RESULTS: c-kit^+ hematopoietic progenitor cells from mice bone marrow cells cultured with cytokines for 8 d showed the character of typical mature DCs.Morphologically, observed by light microscope, these cells were large with oval or irregularly shaped nuclei and with many small dendrites. Phenotypically, FACS analysis showed that they expressed.high levels of la, DEC-205, CD11b, CD80 and CD86 antigen, moderate levels of CD40, and negative for F4/80. Functionally, these cells gained the capacity to stimulate allogeneic T cells in MLR assay. However, immature DCs cultured with cytokines for 5 d did not have typical DCs phenotypic markers and could not stimulate allogeneic T cells. Ex vivo primed T cells with SGC-7901 tumor cell lysate-pulsed (TP) DCs were able to induce effective CTL activity against SGC-7901 tumor cells (E:T = 100:1, 69.55% ± 6.05% specific lysis), but not B16 tumor cells, and produced higher levels of IFNγ, when stimulated with SGC-7901 tumor cells but not when stimulated with B16 tumor cells (1575.31 ± 60.25 pg/mL in SGC-7901 group vs 164.11± 18.52 pg/mL in B16 group, P 〈 0.01). CONCLUSION: BM-derived DCs pulsed with tumor lysates Can induce anti-tumor immunity specific to gastric cancer ex vivo.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第46期7127-7132,共6页 世界胃肠病学杂志(英文版)
关键词 树突细胞 细胞因子 胃癌 细胞毒素 症状 Dendritic cells Cytokine Gastric cancer Cytotoxic T lymphocyte Imrnunotherapy
  • 相关文献

参考文献2

二级参考文献43

  • 1[1]Rougier P,Andre T,Panis Y,Colin P,Stremsdoerfer N,Laurent-Puig P.Colon cancer.Gastroenterol Clin Biol 2006; 30 Spec No 2:2S24-2S29
  • 2[2]McCormick D,Kibbe PJ,Morgan SW.Colon cancer:prevention,diagnosis,treatment.Gastroenterol Nurs 2002; 25:204-211; quiz,211-212
  • 3[3]Colquhoun PH,Wexner SD.Surgical management of colon cancer.Curr Gastroenterol Rep 2002; 4:414-419
  • 4[4]Saif MW.Targeted agents for adjuvant therapy of colon cancer.Clin Colorectal Cancer 2006; 6:46-51
  • 5[5]Okaji Y,Tsuno NH,Kitayama J,Saito S,Takahashi T,Kawai K,Yazawa K,Asakage M,Hori N,Watanabe T,Shibata Y,Takahashi K,Nagawa H.Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity.Cancer Sci 2004; 95:85-90
  • 6[6]Gilboa E.DC-based cancer vaccines.J Clin Invest 2007; 117:1195-1203
  • 7[7]Banchereau J,Steinman RM.Dendritic cells and the control of immunity.Nature 1998; 392:245-252
  • 8[8]Nouri-Shirazi M,Banchereau J,Fay J,Palucka K.Dendritic cell based tumor vaccines.Immunol Lett 2000; 74:5-10
  • 9[9]Nestle FO,Alijagic S,Gilliet M,Sun Y,Grabbe S,Dummer R,Burg G,Schadendorf D.Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells.Nat Med 1998; 4:328-332
  • 10[10]Trinchieri G.Interleukin-12 and the regulation of innate resistance and adaptive immunity.Nat Rev Immunol 2003; 3:133-146

共引文献36

同被引文献50

引证文献16

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部